Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Dow
Medtronic
Colorcon

Last Updated: December 6, 2022

CLINICAL TRIALS PROFILE FOR DETROL


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Detrol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00143481 ↗ Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women Completed Pfizer Phase 4 2005-03-01 The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
NCT00143481 ↗ Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women Completed Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Phase 4 2005-03-01 The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
NCT00147654 ↗ Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction Completed Pfizer Phase 4 2004-11-01 The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Detrol

Condition Name

Condition Name for Detrol
Intervention Trials
Urinary Incontinence 5
Overactive Bladder 4
Overactive Bladder (OAB) 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Detrol
Intervention Trials
Urinary Bladder, Overactive 11
Urinary Incontinence 7
Enuresis 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Detrol

Trials by Country

Trials by Country for Detrol
Location Trials
United States 186
Canada 11
South Africa 4
United Kingdom 4
Mexico 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Detrol
Location Trials
California 10
New York 9
Texas 8
Arizona 8
Florida 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Detrol

Clinical Trial Phase

Clinical Trial Phase for Detrol
Clinical Trial Phase Trials
Phase 4 10
Phase 3 3
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Detrol
Clinical Trial Phase Trials
Completed 15
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Detrol

Sponsor Name

Sponsor Name for Detrol
Sponsor Trials
Pfizer 8
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 5
Astellas Pharma Inc 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Detrol
Sponsor Trials
Industry 20
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Medtronic
AstraZeneca
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.